Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Army
Fuji
Julphar
Chubb
Farmers Insurance
Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Mallinckrodt

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,235,627

« Back to Dashboard

Summary for Patent: 7,235,627
Title:Derivatives of GLP-1 analogs
Abstract:The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
Inventor(s): Knudson; Liselotte Bjerre (Valby, DK), Huusfeldt; Per Olaf (Kobenhavn K, DK), Nielsen; Per Franklin (V.ae butted.rlose, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:10/285,079
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 7,235,627

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novo Nordisk Inc SAXENDA liraglutide recombinant SOLUTION;SUBCUTANEOUS 206321-001 Dec 23, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Novo Nordisk Inc VICTOZA liraglutide recombinant SOLUTION;SUBCUTANEOUS 022341-001 Jan 25, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Novo Nordisk Inc XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583-001 Nov 21, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,235,627

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0931/96Aug 30, 1996
Denmark1259/96Nov 08, 1996
Denmark1470/96Dec 20, 1996
Denmark0263/98Feb 27, 1998
Denmark0264/98Feb 27, 1998
Denmark0268/98Feb 27, 1998
Denmark0272/98Feb 27, 1998
98610006Mar 13, 1998
Denmark0508/98Apr 08, 1998
Denmark0509/98Apr 08, 1998

Non-Orange Book US Patents Family Members for Patent 7,235,627

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,097,698 Derivatives of GLP-1 analogs ➤ Subscribe
6,268,343 Derivatives of GLP-1 analogs ➤ Subscribe
6,384,016 Stabilized aqueous peptide solutions ➤ Subscribe
7,226,990 Extendin derivatives ➤ Subscribe
6,458,924 Derivatives of GLP-1 analogs ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,235,627

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 265224 ➤ Subscribe
Austria 269103 ➤ Subscribe
Austria 356830 ➤ Subscribe
Austria 466026 ➤ Subscribe
Austria 466027 ➤ Subscribe
Austria 466028 ➤ Subscribe
Australia 2610599 ➤ Subscribe
Australia 2610699 ➤ Subscribe
Australia 2610799 ➤ Subscribe
Australia 2610899 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Moodys
Merck
QuintilesIMS
Julphar
Chubb
McKinsey
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot